earnings
AN
NASDAQ · ANIX
Anixa Biosciences, Inc.
Healthcare · Biotechnology
$2.76
Up+$0.01 (+0.36%)
Updated Sep 12, 2026, 2:29 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 99.47M
- P/E ratio
- -8.85
- Dividend yield
- 0.00%
- 52-week range
- $2.32 – $5.46
- Volume
- 389.37K
- Avg. volume
- 307.4K
Price performance
ANIX price history
1M range · 20 trading sessions · Daily adjusted prices
ANIX closed at $2.76 after 20 trading sessions, down 13.21% for the selected period.
- Last close
- $2.76
- Period change
- -13.21%
- Period low
- $2.75
- Period high
- $3.71
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $2.87 | $2.88 | $2.72 | $2.76 | 389.37K |
| Sep 10, 2026 | $2.76 | $2.8085 | $2.66 | $2.75 | 400.15K |
| Sep 9, 2026 | $2.92 | $2.969 | $2.79 | $2.83 | 478.82K |
| Sep 8, 2026 | $3.10 | $3.20 | $2.875 | $2.90 | 442.11K |
| Sep 4, 2026 | $3.03 | $3.105 | $3.00 | $3.07 | 368.21K |
| Sep 3, 2026 | $3.14 | $3.2519 | $2.99 | $3.05 | 409.26K |
| Sep 2, 2026 | $3.28 | $3.39 | $3.12 | $3.13 | 335.03K |
| Sep 1, 2026 | $3.405 | $3.49 | $3.23 | $3.28 | 342.5K |
| Aug 31, 2026 | $3.43 | $3.63 | $3.31 | $3.35 | 353.29K |
| Aug 28, 2026 | $3.60 | $3.67 | $3.42 | $3.48 | 215.06K |
| Aug 27, 2026 | $3.60 | $3.675 | $3.52 | $3.60 | 337.55K |
| Aug 26, 2026 | $3.64 | $3.7528 | $3.47 | $3.605 | 291.8K |
| Aug 25, 2026 | $3.64 | $3.8724 | $3.62 | $3.66 | 608.41K |
| Aug 24, 2026 | $3.66 | $3.73 | $3.51 | $3.62 | 138.81K |
| Aug 21, 2026 | $3.64 | $3.755 | $3.60 | $3.71 | 182.55K |
| Aug 20, 2026 | $3.69 | $3.71 | $3.55 | $3.59 | 168.53K |
| Aug 19, 2026 | $3.49 | $3.81 | $3.46 | $3.71 | 569.59K |
| Aug 18, 2026 | $3.41 | $3.4937 | $3.33 | $3.43 | 117.84K |
| Aug 17, 2026 | $3.18 | $3.50 | $3.1401 | $3.49 | 315.44K |
| Aug 14, 2026 | $3.20 | $3.2306 | $3.10 | $3.18 | 107.83K |
Latest ANIX news
The latest Smart Investors Daily articles mentioning ANIX.
Stock researchCompany · Forecast
Loading stock research…